Rethinking Parkinson's: Immune insights from brain-resident and peripheral cells offer new therapeutic hopes
Peer-Reviewed Publication
Updates every hour. Last Updated: 11-Jan-2026 08:11 ET (11-Jan-2026 13:11 GMT/UTC)
Neurodegenerative diseases, traditionally viewed as driven by neuronal decline, are increasingly recognized to involve significant immune dysfunction within and outside the central nervous system (CNS). A new review by Professor Qiang Liu's team at Tianjin Medical University General Hospital synthesizes evidence that dynamic interactions between brain-resident and peripheral immune cells are crucial in diseases like Parkinson's disease (PD), offering fresh perspectives for developing treatments that can modify disease progression.
Potentially more than 90% of Alzheimer’s disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by University College London (UCL) researchers.
Drugs that act against bacteria are mainly assessed based on how well they inhibit bacterial growth under laboratory conditions. A critical factor, however, is whether the active substances actually kill the pathogens in the body. Researchers at the University of Basel have presented a new method for measuring how effectively antibiotics kill bacteria.